Bionime
- Company typePrivate
- Founded2003
- HeadquartersTaichung, Taiwan
- Headcount501–1,000
- GTM typeB2C
- OfferingHardware or Manufacturing
Bionime firmographics
Firmographics- Name
- Bionime
- Website
- https://bionime.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Bionime industry classification
Industry- Product category
- Blood Glucose Monitoring Devices
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG)
- akta.pro secondary industries
- Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE), Blood Glucose & Metabolic POCT (Glucose, Ketones, Lactate) (HLAHAOAB)
Keywords
Where Bionime is headquartered
LocationHeadquarters
- HQ city
- Taichung
- HQ country
- Taiwan
- HQ region
- Asia
Markets served
Bionime business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D
Bionime product offering
Product offeringCore offering
Bionime designs, manufactures, and distributes blood glucose monitoring devices for diabetic patients who require regular glucose measurement and disease management. The company operates in the biotechnology and medical testing sector, producing diagnostic hardware used by individuals managing diabetes.
Differentiator
Problem solved
Functional benefit
Products and services
- Blood Glucose Monitoring Devices Handheld blood glucose monitoring devices designed for diabetic patients who require regular glucose measurement for self-management of their condition. Sold to individual consumers managing diabetes.
Companies that use Bionime
Customer profileSegments1 record
Ideal customer profiles1 record
Bionime technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bionime partnerships and signals
Strategic signalScale indicators1 record
Recent moves1 record
Expansion highlights3 records
Bionime competitors and assessment
Company assessmentDirect peers
- Sinocare: Chinese blood glucose monitoring device manufacturer with similar scale and Asian manufacturing base; directly comparable mid-size BGM peer to Bionime.
- Trividia Health: US-based manufacturer of TRUE brand blood glucose meters and test strips, a comparable mid-size BGM specialist.
- LifeScan: OneTouch brand maker of blood glucose monitoring systems and consumables — a direct BGM peer competing for the same diabetic patient segment as Bionime.
- Ascensia Diabetes Care: Owns the CONTOUR blood glucose monitoring portfolio and competes head-to-head with Bionime in the BGM meters and strips category globally.
- Nova Biomedical: Manufacturer of point-of-care and self-monitoring blood glucose analyzers used in hospital and patient settings — overlaps with Bionime in glucose measurement technology.
Broad incumbents
- Roche Diabetes Care: Manufactures the Accu-Chek line of blood glucose meters and test strips, a direct BGM competitor to Bionime, operating as part of Roche's much larger diagnostics portfolio.
- Abbott Diabetes Care: Sells FreeStyle Libre CGM and FreeStyle blood glucose meters, named alongside Bionime in the Saudi Arabia market and a benchmark global diabetes device competitor.
- Dexcom: Leading CGM manufacturer explicitly identified as a competitor to Bionime in the Saudi market; competes for diabetes monitoring share with a different technology approach.
- Medtronic Diabetes: Major diabetes care player offering insulin pumps and BGM/CGM systems, named as a fellow competitor to Bionime in Saudi Arabia.
Emerging players
- ARKRAY: Japanese diagnostics manufacturer of blood glucose meters and POCT devices for both consumer and clinical use, comparable in mid-sized BGM and POCT orientation.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights5 records
Customer concentration
Bionime social profiles
Digital presenceBionime financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bionime leadership team
Management profileNumber of profiles
Bionime funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bionime M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bionime
What does Bionime do?
Bionime designs, manufactures, and distributes blood glucose monitoring devices for diabetic patients who require regular glucose measurement and disease management. The company operates in the biotechnology and medical testing sector, producing diagnostic hardware used by individuals managing diabetes.
When was Bionime founded?
Bionime was founded in 2003. It employs 501 to 1,000 people.
Where is Bionime based?
Bionime is headquartered in Taichung, Taiwan, in the Asia region.
Who are Bionime's main competitors?
Direct peers on record are Sinocare, Trividia Health, LifeScan, Ascensia Diabetes Care and Nova Biomedical. Broad incumbents are Roche Diabetes Care, Abbott Diabetes Care, Dexcom and Medtronic Diabetes. ARKRAY is listed as an emerging player.
Does Bionime have an API?
No public API is recorded for Bionime.
What industry is Bionime in?
Bionime's product category is Blood Glucose Monitoring Devices. Its primary akta.pro industry code is HLAHAHAG, Blood Glucose Monitoring (BGM) Meters & Test Strips, with a secondary code of CRACAQAE, Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers). Its NAICS code is 3345 and its SIC code is 3841.